We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

121 hedge funds and large institutions have $451M invested in Arena Pharmaceuticals Inc in 2014 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 39 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less funds holding

Funds holding: 129 → 121 (-8)

13% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 39

28% less capital invested

Capital invested by funds: $628M → $451M (-$177M)

33% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 21

50% less call options, than puts

Call options by funds: $12.7M | Put options by funds: $25.4M

Holders
121
Holders Change
-8
Holders Change %
-6.2%
% of All Funds
3.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
34
Reduced
39
Closed
21
Calls
$12.7M
Puts
$25.4M
Net Calls
-$12.6M
Net Calls Change
+$7.61M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$7.74M
2
DM
Deerfield Management
New York
+$6.6M
3
Invesco
Invesco
Georgia
+$5.24M
4
State Street
State Street
Massachusetts
+$4.13M
5
Group One Trading
Group One Trading
Illinois
+$3.3M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$9.76M
2
Norges Bank
Norges Bank
Norway
-$8.62M
3
PAMU
Pictet Asset Management (UK)
United Kingdom
-$2.96M
4
Goldman Sachs
Goldman Sachs
New York
-$2.76M
5
Charles Schwab
Charles Schwab
California
-$1.85M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCMH
126
Cornerstone Capital Management Holdings
New York
– -$230K -3,940 Closed
GCP
127
GSA Capital Partners
United Kingdom
– -$186K -3,175 Closed
VKH
128
Virtu KCG Holdings
New York
– -$169K -2,876 Closed
PAM
129
Princeton Alpha Management
New Jersey
– -$103K -1,754 Closed
FA
130
FCG Advisors
New Jersey
– -$62K -1,060 Closed
WAM
131
World Asset Management
Michigan
– -$59K -1,006 Closed
MCM
132
MAI Capital Management
Ohio
– -$59K -1,000 Closed
Bank of Montreal
133
Bank of Montreal
Ontario, Canada
– -$35K -604 Closed
SO
134
STRS Ohio
Ohio
– -$25.4K -570 Closed
MFS
135
MSI Financial Services
Massachusetts
– -$15K -250 Closed
BWFA
136
Baltimore-Washington Financial Advisors
Maryland
– -$6K -100 Closed
WA
137
WFG Advisors
Texas
– -$6K -100 Closed
ST
138
Spot Trading
Illinois
– -$2.95K -66 Closed
NES
139
New England Securities
New York
– -$3K -50 Closed
AA
140
Apriem Advisors
California
– -$1K -20 Closed
HRIA
141
Haberer Registered Investment Advisor
Ohio
– -$1K -20 Closed
2 3 4 5
6

ARNA Hedge Fund Activity: Q3 2014 in Review

121 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2014, worth a combined $451M — down 28% from $628M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ARNA and 14 opened new positions — a net loss of 7 holders — while 39 trimmed existing stakes and 34 added.

The largest buyer was Wellington Management Group, adding an estimated $7.74M. The largest seller was Morgan Stanley, cutting an estimated $9.76M.

  • 121 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2014, down from 129 in Q2 2014.
  • Funds reported $451M of Arena Pharmaceuticals Inc stock for Q3 2014, down 28% quarter-over-quarter.
  • 14 funds opened new Arena Pharmaceuticals Inc positions in Q3 2014 and 21 closed out, a net change of -7 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q3 2014 was Wellington Management Group, an estimated $7.74M added.
  • The largest Arena Pharmaceuticals Inc seller in Q3 2014 was Morgan Stanley, an estimated $9.76M sold.

Based on aggregated 13F filings for Q3 2014.